Sphingolipid dysregulation in erythrocytes during sickle cell disease contributes to pro-inflammatory microparticle generation and subsequent inflammatory cell activation
Sickle cell disease is a hereditary blood disorder caused by a point mutation in the gene encoding hemoglobin. This mutation causes hemoglobin molecules to polymerize during de-oxygenation of erythrocytes producing rod-shaped polymers that bend and distort the red blood cell membrane, making it more...
Main Author: | Awojoodu, Anthony O. |
---|---|
Other Authors: | Botchwey, Edward A. |
Format: | Others |
Language: | en_US |
Published: |
Georgia Institute of Technology
2016
|
Subjects: | |
Online Access: | http://hdl.handle.net/1853/54286 |
Similar Items
-
Macrophage Activation in Sickle Cell Disease: The Role of Sphingolipid Metabolism in the Disease State
by: Lane, Alicia Renee
Published: (2015) -
Circulating microparticles, protein C, free protein S and endothelial vascular markers in children with sickle cell anaemia
by: Andrea Piccin, et al.
Published: (2015-11-01) -
Association Between Nitric Oxide, Oxidative Stress, Eryptosis, Red Blood Cell Microparticles, and Vascular Function in Sickle Cell Anemia
by: Elie Nader, et al.
Published: (2020-11-01) -
Role of Microparticles in the Pathogenesis of Inflammatory Joint Diseases
by: Magdalena Krajewska-Włodarczyk, et al.
Published: (2019-11-01) -
Sphingolipids Modulate the Inflammatory and Functional Response in mdx Mice
by: Doering, Jonathan Adam
Published: (2015)